Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: A retrospective analysis

Journal of Clinical Oncology

Volumn 22, Issue 8, 2004, Pages 1501-1509

  Ströbel, Philipp ^a   Bauer, Andrea ^a   Puppe, Bernhard ^a   Kraushaar, Til ^a   Krein, Axel ^a   Toyka, Klaus ^a   Gold, Ralf ^a   Semik, Michael ^a   Kiefer, Reinhard ^a   Nix, Wilfred ^a   Schalke, Berthold ^a   Müller Hermelink, Hans Konrad ^a   Marx, Alexander ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; THYMOMA; THYMUS CANCER; TREATMENT OUTCOME; TUMOR RECURRENCE; FOLLOW UP; MORTALITY; PATHOLOGY; SURVIVAL RATE;

CARCINOMA, SQUAMOUS CELL; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYMOMA; THYMUS NEOPLASMS;

EID: 2342510977     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.10.113     Document Type: Article

References (31)

1. Rosai J, Sobin L: Histological typing of tumours of the thymus, in Anonymous: World Health Organization, International Histological Classification of Tumours. Heidelberg, Springer, 1999, pp 1-16
2. Sperling B, Marschall J, Kennedy R, et al: Thymoma: A review of the clinical and pathological findings in 65 cases. Can J Surg 46:37-42, 2003
3. Kornstein MJ, Curran WJ Jr, Turrisi AT 3rd, et al: Cortical versus medullary thymomas: A useful morphologic distinction? Hum Pathol 19:1335-1339, 1988
4. Pan CC, Chen WY, Chiang H, et al: A multivariate analysis of prognostic factors in thymoma. Zhonghua Yi Xue Za Zhi (Taipei) 56:120-124, 1995
5. Quintanilla-Martinez L, Wilkins EW Jr, Choi N, et al: Thymoma. Histologic subclassification is an independent prognostic factor. Cancer 74:606-617, 1994
6. Suster S, Moran CA: Thymoma classification: The ride of the valkyries? Am J Clin Pathol 112:308-310, 1999
7. Chen G, Marx A, Wen-Hu C, et al: New WHO histologic classification predicts prognosis of thymic epithelial tumors: A clinicopathologic study of 200 thymoma cases from China. Cancer 95:420-429, 2002
8. Okumura M, Ohta M, Miyoshi S, et al: Oncological significance of WHO histological thymoma classification. A clinical study based on 286 patients. Jpn J Thorac Cardiovasc Surg 50189-194, 2002
9. Rieker RJ, Hoegel J, Morresi-Hauf A, et al: Histologic classification of thymic epithelial tumors: Comparison of established classification schemes. Int J Cancer 98:900-906, 2002
10. Suster S, Moran CA: Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma: A clinicopathologic study of 22 cases. Am J Surg Pathol 201469-1480, 1996
11. Koga K, Matsuno Y, Noguchi M, et al: A review of 79 thymomas: Modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 44:359-367, 1994
12. Loehrer PJ Sr, Chen M, Kim K, et al: Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: An intergroup trial. J Clin Oncol 15:3093-3099, 1997
13. Okumura M, Ohta M, Tateyama H, et al: The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: A clinical study of 273 patients. Cancer 94:624-632, 2002
14. Chalabreysse L, Roy P, Cordier JF, et al: Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: A retrospective study of 90 tumors. Am J Surg Pathol 26:1605-1611, 2002
15. Nakagawa K, Asamura H, Matsuno Y, et al: Thymoma: A clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 126:1134-1140, 2003
16. Whooley BP, Urschel JD, Antkowiak JG, et al: A 25-year thymoma treatment review. J Exp Clin Cancer Res 19:3-5, 2000
17. Kirchner T, Schalke B, Buchwald J, et al: Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol 16:1153-1169, 1992
18. Agrawal S, Datta NR, Mishra SK, et al: Adjuvant therapy in invasive thymoma: An audit of cases treated over an 8 year period. Indian J Cancer 36:46-56, 1999
19. Berruti A, Tampellini M, Gorzegno G, et al: Objective response to epirubicin and lonidamine. A case of advanced thymoma previously treated with the ADOC scheme and unresponsive to paclitaxel plus cyclophosphamide. Chest 111:1473-1474, 1997
20. Berruti A, Borasio P, Gerbino A, et al: Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: A single institution experience. Br J Cancer 81:841-845, 1999
21. Chahinian AP: Chemotherapy of thymomas and thymic carcinomas. Chest Surg Clin N Am 11:447-456, 2001
22. Kondo K, Monden Y: Therapy for thymic epithelial tumors: A clinical study of 1,320 patients from Japan. Ann Thorac Surg 76:878-885, 2003
23. Takahashi K, Yoshida J, Nishimura M, et al: Thymic carcinoma. Outcome of treatment including surgical resection. Jpn J Thorac Cardiovasc Surg 48:494-198, 2000
24. Schmidt-Wolf IG, Rockstroh JK, Schuller H, et al: Malignant thymoma: Current status of classification and multimodality treatment. Ann Hematol 82:69-76, 2003
25. Ruffini E, Mancuso M, Oliaro A, et al: Recurrence of thymoma: Analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg 113:55-63, 1997
26. Ogawa K, Uno T, Toita T, et al: Postoperative radiotherapy for patients with completely resected thymoma: A multi-institutional, retrospective review of 103 patients. Cancer 94:1405-1413, 2002
27. Gripp S, Hilgers K, Wurm R, et al: Thymoma: Prognostic factors and treatment outcomes. Cancer 83:1495-1503, 1998
28. Eralp Y, Aydiner A, Kizir A, et al: Resectable thymoma: Treatment outcome and prognostic factors in the late adolescent and adult age group. Cancer Invest 21:737-743, 2003
29. Mangi AA, Wright CD, Allan JS, et al: Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg 74:1033-1037, 2002
30. Singhal S, Shrager JB, Rosenthal DI, et al: Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 76:1635-1642, 2003
31. Venuta F, Rendina EA, Longo F, et al: Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 76:1866-1872, 2003